These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35149774)

  • 21. Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.
    Seibert TM; Garraway IP; Plym A; Mahal BA; Giri V; Jacobs MF; Cheng HH; Loeb S; Helfand BT; Eeles RA; Morgan TM
    Eur Urol; 2023 Mar; 83(3):241-248. PubMed ID: 36609003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer.
    Darst BF; Dadaev T; Saunders E; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Gapstur SM; Stevens V; Albanes D; Weinstein SJ; Gnanapragasam V; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz M; Schmidt JA; Mucci L; Catalona WJ; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Kote-Jarai Z; Conti DV; Haiman CA
    J Natl Cancer Inst; 2021 May; 113(5):616-625. PubMed ID: 32853339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.
    Brady L; Newcomb LF; Zhu K; Zheng Y; Boyer H; Sarkar N; McKenney JK; Brooks JD; Carroll PR; Dash A; Ellis WJ; Filson CP; Gleave ME; Liss MA; Martin F; Morgan TM; Thompson IM; Wagner AA; Pritchard CC; Lin DW; Nelson PS
    Cancer Med; 2022 Nov; 11(22):4332-4340. PubMed ID: 35467778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing.
    Giri VN; Hegarty SE; Hyatt C; O'Leary E; Garcia J; Knudsen KE; Kelly WK; Gomella LG
    Prostate; 2019 Mar; 79(4):333-339. PubMed ID: 30450585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impact of germline BRCA2 and CHEK2 mutations on time to castration resistance in patients with metastatic hormone-nave prostate cancer].
    Matveev VB; Kirichek AA; Filippova MG; Savinkova AV; Khalmurzaev OA; Lyubchenko LN
    Urologiia; 2019 Dec; (5):79-85. PubMed ID: 31808637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
    Antonarakis ES; Lu C; Luber B; Liang C; Wang H; Chen Y; Silberstein JL; Piana D; Lai Z; Chen Y; Isaacs WB; Luo J
    Eur Urol; 2018 Aug; 74(2):218-225. PubMed ID: 29439820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commentary on "Inherited DNA-repair gene mutations in men with metastatic prostate cancer". Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016;375(5):443-53.
    Freedland SJ; Aronson WJ
    Urol Oncol; 2017 Aug; 35(8):536-537. PubMed ID: 28623070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inherited Mutations in Chinese Men With Prostate Cancer.
    Zhu Y; Wei Y; Zeng H; Li Y; Ng CF; Zhou F; He C; Sun G; Ni Y; Chiu PKF; Teoh JYC; Wang B; Pan J; Wan F; Dai B; Qin X; Lin G; Gan H; Wu J; Ye D
    J Natl Compr Canc Netw; 2021 Oct; 20(1):54-62. PubMed ID: 34653963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate Cancer.
    Chávarri-Guerra Y; Bourlon MT; Rodríguez-Olivares JL; Orozco L; Bazua D; Rodríguez-Faure A; Alcalde-Castro MJ; Castro E; Castillo D; Herzog J; Weitzel J
    Clin Genitourin Cancer; 2023 Oct; 21(5):569-573. PubMed ID: 37380563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer.
    Annala M; Struss WJ; Warner EW; Beja K; Vandekerkhove G; Wong A; Khalaf D; Seppälä IL; So A; Lo G; Aggarwal R; Small EJ; Nykter M; Gleave ME; Chi KN; Wyatt AW
    Eur Urol; 2017 Jul; 72(1):34-42. PubMed ID: 28259476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk.
    Alvarez-Cubero MJ; Pascual-Geler M; Martinez-Gonzalez LJ; Expósito Ruiz M; Saiz M; Cozar JM; Lorente JA
    Urol Oncol; 2016 Oct; 34(10):431.e1-8. PubMed ID: 27318894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.
    Akamatsu S; Terada N; Takata R; Kinoshita H; Shimatani K; Momozawa Y; Yamamoto M; Tada H; Kawamorita N; Narita S; Kato T; Nitta M; Kandori S; Koike Y; Inazawa J; Kimura T; Kimura H; Kojima T; Terachi T; Sugimoto M; Habuchi T; Arai Y; Yamamoto S; Matsuda T; Obara W; Kamoto T; Inoue T; Nakagawa H; Ogawa O
    JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35118230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
    Sabol RA; Ledet EM; Jaeger E; Hatton W; Moses M; Lankford A; Zaheria A; Barata P; Layton JL; Lewis BE; Sartor O
    Prostate; 2021 May; 81(7):427-432. PubMed ID: 33760238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial.
    Shore N; Gazi M; Pieczonka C; Heron S; Modh R; Cahn D; Belkoff LH; Berger A; Mazzarella B; Veys J; Idom C; Morris D; Jayram G; Engelman A; Bukkapatnam R; Dato P; Bevan-Thomas R; Cornell R; Wise DR; Hardwick MK; Hernandez RD; Rojahn S; Layman P; Hatchell KE; Heald B; Nussbaum RL; Nielsen SM; Esplin ED
    Eur Urol Oncol; 2023 Oct; 6(5):477-483. PubMed ID: 37574391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
    Wu Y; Yu H; Zheng SL; Na R; Mamawala M; Landis T; Wiley K; Petkewicz J; Shah S; Shi Z; Novakovic K; McGuire M; Brendler CB; Ding Q; Helfand BT; Carter HB; Cooney KA; Isaacs WB; Xu J
    Prostate; 2018 Jun; 78(8):607-615. PubMed ID: 29520813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of DNA-Repair Gene mutations in Mexican men with prostate cancer.
    Cruz Garcia Villa P; Izunza Laisequilla A; Puga Ortega E; Alaez Verson C
    Actas Urol Esp (Engl Ed); 2024 Oct; 48(8):588-595. PubMed ID: 38735436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline variants in early and late-onset Brazilian prostate cancer patients.
    Coelho KBCA; Squire JA; Duarte KG; Sares CTG; Moreda NA; Pereira JL; da Silva IT; Defelicibus A; Aoki MN; Rivas JL; Dos Reis RB; Zanette DL
    Urol Oncol; 2024 Mar; 42(3):68.e11-68.e19. PubMed ID: 38311546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis.
    Na R; Wu Y; Jiang G; Yu H; Lin X; Wang M; Conran CA; Fantus RJ; Zhang N; Liu S; Helfand BT; Zheng SL; Isaacs WB; Ding Q; Shen Z; Xu J
    BJU Int; 2018 Nov; 122(5):808-813. PubMed ID: 29727914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer.
    Januskevicius T; Vaicekauskaite I; Sabaliauskaite R; Matulevicius A; Vezelis A; Ulys A; Jarmalaite S; Jankevicius F
    Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.